PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL) explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL) trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New PET tracer may spot rare tumors better than current standard
Diagnosis Recruiting nowThis study tests a newer type of PET/CT scan (Al18F-NOTA-LM3) against the current standard (68Ga-DOTATATE) to see which finds tumors more accurately in people with rare adrenal or nerve tumors called pheochromocytoma or paraganglioma. About 40 adults aged 18-80 with suspected or …
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 22, 2026 13:54 UTC
-
New PET tracer could spot hidden cancers better than current scans
Diagnosis Recruiting nowThis study is testing whether a new PET imaging tracer called [18F]FAPI-74 can find tumors as well as or better than the standard tracer in adults with certain cancers (like pancreatic, ovarian, or lung cancer). Participants will get both types of scans to compare how many tumors…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated May 18, 2026 12:09 UTC